Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
indicating an overall improvement of the condition in experimental autoimmune encephalomyelitis (EAE)-induced wild-type C57Bl/6 mice
88 mM) H2O : < 0
The facilitation of GluN2C/GluN2D-containing receptors may serve as an important therapeutic strategy for treating positive and cognitive symptoms in schizophrenia
enterococci and staphylococci
OTSSP167 - CAS# 1431697-89-0 D 169316 indicating an overall improvement ofOTSSP167, also known as OTS167, is an orally available inhibitor of maternal embryonic leucine zipper kinase (MELK) with potential antineoplastic activity. Upon administration, OTS167 binds to MELK, which prevents both MELK phosphorylation and activation; thus inhibiting the phosphorylation of downstream MELK substrates. This may lead to an inhibition of both cell proliferation and survival in MELK expressing tumor cells. Product information CAS
US$ 50.00
US$ 22.99
US$ 38.00
US$ 190.00
US$ 200.00
US$ 68.00
US$ 44.00
US$ 149.00
US$ 18.99